Our Future

WUND Healing BioPharmaceuticals owns the exclusive rights to sell all of the biologic drugs being developed by U.S.-based Zhittya Genesis Medicine for the territory of the United States and Canada. The drugs that WUND owns the rights to, address human diseases which cause over 50% of all deaths in the U.S. and Canada.

WUND Has the Exclusive Rights to the Drugs for the Following Medical Indications:

Over $130 Million USD Has Been Expended Advancing & Developing These Drugs

Share this: